Clinical trial Recruiting at 1 site Interventional Ages 12 to 21 Women only

Understanding how the brain communicates in young people with Postural Tachycardia Syndrome

Official title: Pediatric POTS: Does a Periaqueductal Gray-vagus Nerve Interface Malfunction Explain the Natural History With Its Numerous Co-morbidities?

Run by Virginia Commonwealth University · NCT05618054 · Data updated 2026-11-12

This study is testing how young people with Postural Tachycardia Syndrome understand visual information to see how their brain communicates differently compared to healthy peers.

Quick facts

Study typeInterventional
Ages12 Years to 21 Years
SexWomen only
Enrollment36 (estimated)
SponsorVirginia Commonwealth University
Academic / other
Locations1 site (Richmond, Virginia)
StatusRecruiting
StartedMarch 6, 2023
Main results expectedDecember 2026
Study endsDecember 2026
Registry record updatedApril 21, 2026
Trial IDNCT05618054 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are females aged 12-21 who have been diagnosed with POTS and can communicate effectively.

Probably not a fit

Patients with chronic neurological disorders or significant unstable medical conditions may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study investigates how individuals aged 12-21 with Postural Tachycardia Syndrome (POTS) perceive and interpret visual information. By utilizing a looming task, researchers aim to explore the communication between different brain regions in these patients. The findings may provide insights into the natural history of POTS and its associated co-morbidities, potentially enhancing the understanding of this condition. The study includes age-matched healthy controls for comparative analysis.

Why it matters

Potential benefit: If successful, this research could lead to improved diagnostic and therapeutic strategies for patients with POTS.

How similar studies have gone: While this approach is relatively novel, similar studies exploring brain function in POTS have shown promise in understanding the condition.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Females 12-21 years old
* Able to communicate and provide consent/assent
* English speaking
* Diagnosed with POTS (POTS will be defined standardly as a symptomatic ≥ 40 bpm rise in heart rate without a drop in blood pressure and with symptoms of orthostatic intolerance clinically)
* Age-matched healthy control subjects: no POTS or other neurological disorders

Exclusion Criteria:

* Inflammatory arthritis, connective tissue or auto-immune disorder
* Any chronic neurological disorder besides POTS
* Evidence of unstable medical disorder, such as kidney (rising creatinine, or end-stage renal failure) or liver impairment (rising AST or ALT, or end-stage with coagulopathy), poorly controlled significant cardiovascular (CHF), respiratory, endocrine (diabetes - A1c \> 9 - or untreated thyroid dysfunction) or uncontrolled psychiatric illness (such as untreated depression, psychosis, etc.)
* Neuropathy, central nervous system disorder (e.g., Cerebral palsy, developmental delay, seizure disorder, MS, stroke, etc.)
* Treatment with a drug or medical device within the previous 30 days that has not received regulatory approval
* Use of hormones (except insulin, thyroid replacement or oral contraceptives, which will be carefully documented)
* Current substance or alcohol abuse
* Any major surgical intervention with general anesthesia in the last 60 days and minor procedure, such as tooth extraction, endoscopy, etc., with local or conscious sedation within 7 days
* Any on-going or pending medical, health or disability related litigation, or current pursuit of disability
* Any condition that in the judgment of the investigator would interfere with the patient's ability to provide informed consent, comply with study instructions, place the patient at increased risk, or which would clearly confound the interpretation of the study results (specific reason will be documented)
* Chronic use of narcotics for pain
* Claustrophobia or any metal hardware that may interfere with MRI
* Investigators and study staff

Where it's running

  • Virginia Commonwealth University
    Richmond, Virginia, United States
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.